Charles Schwab’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.54M | Buy |
358,046
+46,830
| +15% | +$724K | ﹤0.01% | 2293 |
|
|
2025
Q1 | $4.63M | Buy |
311,216
+57,665
| +23% | +$857K | ﹤0.01% | 2305 |
|
|
2024
Q4 | $3.36M | Buy |
253,551
+66,386
| +35% | +$879K | ﹤0.01% | 2520 |
|
|
2024
Q3 | $2.66M | Buy |
187,165
+27,628
| +17% | +$393K | ﹤0.01% | 2619 |
|
|
2024
Q2 | $2.06M | Buy |
159,537
+45,770
| +40% | +$592K | ﹤0.01% | 2694 |
|
|
2024
Q1 | $1.58M | Buy |
113,767
+60,323
| +113% | +$838K | ﹤0.01% | 2660 |
|
|
2023
Q4 | $763K | Sell |
53,444
-18,337
| -26% | -$262K | ﹤0.01% | 2919 |
|
|
2023
Q3 | $1.11M | Buy |
71,781
+22,218
| +45% | +$344K | ﹤0.01% | 2762 |
|
|
2023
Q2 | $779K | Buy |
49,563
+18,000
| +57% | +$283K | ﹤0.01% | 2854 |
|
|
2023
Q1 | $520K | Buy |
31,563
+18,745
| +146% | +$309K | ﹤0.01% | 2933 |
|
|
2022
Q4 | $200K | Buy |
+12,818
| New | +$200K | ﹤0.01% | 3185 |
|